Recombinant Streptococcus gordonii tRNA dimethylallyltransferase (miaA)

Shipped with Ice Packs
In Stock

Description

Enzymatic Function and Substrate Specificity

MiaA catalyzes the transfer of a dimethylallyl group from dimethylallyl pyrophosphate (DMAPP) to adenosine at position 37 (A37) of tRNAs decoding UNN codons (e.g., tRNAPhe^{\text{Phe}}, tRNATrp^{\text{Trp}}) . This prenylation stabilizes codon-anticodon interactions, preventing frameshifting and enhancing translational accuracy . In Escherichia coli, MiaA activity is a prerequisite for subsequent methylthiolation by MiaB, forming ms2^2i6^6A-37, a modification critical for stress responses and virulence .

Key Catalytic Features:

FeatureDescriptionSource Organism
SubstrateAdenosine-37 in UNN-decoding tRNAsE. coli , P. aeruginosa
CofactorDMAPP (dimethylallyl pyrophosphate)P. aeruginosa
Structural MotifCentral substrate channel; conserved P-loop for pyrophosphate recognitionP. aeruginosa
Post-Translational RoleModulates proteome plasticity under stressE. coli

Recombinant Production and Applications

While S. gordonii MiaA has not been explicitly characterized, recombinant MiaA from Streptococcus agalactiae (UniProt Q3K0P1) provides a model for production and purification :

Production Protocol:

  • Expression Host: Escherichia coli

  • Purification: Affinity chromatography (His-tag)

  • Purity: >85% (SDS-PAGE)

  • Stability: Lyophilized form stable for 12 months at -80°C

Recombinant MiaA enables biochemical assays (e.g., prenylation kinetics) and structural studies, though S. gordonii-specific variants require genomic exploration.

Biological and Clinical Relevance

In pathogenic bacteria like extraintestinal E. coli (ExPEC), MiaA levels dynamically adjust under stress, acting as a "rheostat" to realign proteome output . MiaA ablation or overexpression disrupts:

  • Virulence: Reduced fitness in infection models .

  • Stress Responses: Impaired resolution of DNA-protein crosslinks .

  • Antibiotic Resistance: Potential links to TetR-family regulators in S. gordonii .

Hypothesized Roles in S. gordonii:

  1. Oral Colonization: Modulating tRNA modifications may enhance biofilm formation or mucosal adherence .

  2. Commensal-Pathogen Transition: MiaA-driven proteome shifts could facilitate endocarditis progression .

Research Gaps and Future Directions

  1. Genomic Analysis: S. gordonii’s MiaA homolog remains unannotated; comparative genomics could identify its locus.

  2. Functional Studies: Heterologous expression in E. coli or S. gordonii knockout models are needed to validate enzymatic activity.

  3. Therapeutic Targeting: MiaA inhibitors might disrupt bacterial translation without affecting human homologs (e.g., hTrmt10a).

Product Specs

Form
Lyophilized powder. We will ship the format in stock. If you have specific format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. For dry ice shipment, contact us in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
miaA; SGO_0992; tRNA dimethylallyltransferase; EC 2.5.1.75; Dimethylallyl diphosphate:tRNA dimethylallyltransferase; DMAPP:tRNA dimethylallyltransferase; DMATase; Isopentenyl-diphosphate:tRNA isopentenyltransferase; IPP transferase; IPPT; IPTase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-294
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Streptococcus gordonii (strain Challis / ATCC 35105 / BCRC 15272 / CH1 / DL1 / V288)
Target Names
miaA
Target Protein Sequence
MKTKIIVIVG PTAVGKTALS IEVAKAFNGQ IISGDSQQVY RGLNIGTAKI RPEEQEGISH YLLDVRDVGE SYSAYDFVTE ATQAIREIEA QGQLPIICGG TGLYIQSLLE GYHLGGSVPH EEILAYRAQL DSWSDEDLFG KIAELGIEIP QINRRRAMRA LEIAHLGGQL ENNLPDYEAL LICLDDKREK LYERINQRVD LMIEDGLLEE ARWLFDKAPT SQASKGIGYK ELFPYFAGQV SLEEAVDKLK QNTRRFAKRQ LTWFRNRMSV TFYQVGNPDY KNQVMEDIKN FLDK
Uniprot No.

Target Background

Function
Catalyzes the transfer of a dimethylallyl group to the adenine at position 37 in tRNAs that read codons beginning with uridine, forming N6-(dimethylallyl)adenosine (i(6)A).
Database Links
Protein Families
IPP transferase family

Q&A

What is the biochemical function of tRNA dimethylallyltransferase (MiaA) in bacteria?

MiaA functions as a tRNA prenyltransferase that catalyzes the addition of a prenyl group onto the N6-nitrogen of adenosine-37 (A-37) in tRNAs that decode UNN codons, creating i6A-37 tRNA . This modification is subsequently methylthiolated by MiaB to create ms2i6A-37. The bulky and hydrophobic ms2i6A-37 modification enhances tRNA interactions with UNN target codons, promoting reading frame maintenance and translational fidelity . This post-transcriptional modification mechanism is highly conserved across prokaryotes and eukaryotes, though the specific enzymes mediating this modification have diverged in evolutionarily distant organisms .

How does MiaA activity impact bacterial physiology?

MiaA activity profoundly influences bacterial physiology through several mechanisms:

  • Translational fidelity: MiaA modifications enhance codon-anticodon interactions for UNN-recognizing tRNAs, reducing frameshifting errors .

  • Stress response: Studies in E. coli demonstrate that MiaA levels shift in response to stress via post-transcriptional mechanisms, resulting in marked changes in the amounts of fully modified MiaA substrates .

  • Proteome modulation: Both ablation and overproduction of MiaA stimulate translational frameshifting and profoundly alter the bacterial proteome .

  • Virulence: MiaA has been shown to be crucial to the fitness and virulence of extraintestinal pathogenic E. coli (ExPEC) .

In mutants lacking miaA, several phenotypes have been observed, including impaired attenuation of tryptophan and phenylalanine operons, diminished translation of stationary phase factors, inability to effectively resolve aberrant DNA-protein crosslinks, and elevated spontaneous mutation frequencies .

Why is Streptococcus gordonii considered a suitable host for recombinant protein expression?

S. gordonii possesses several characteristics that make it an attractive host for recombinant protein expression:

  • Commensal status: As a human oral commensal, S. gordonii has evolved to persist in the human body without causing disease, making it potentially safe for use in vivo .

  • Surface display capacity: S. gordonii can efficiently express and anchor heterologous proteins to its cell surface, as demonstrated with various fusion proteins .

  • Mucosal delivery vehicle: S. gordonii has been developed as a model system for mucosal delivery of heterologous proteins, making it valuable for vaccine development .

  • Natural transformation competence: S. gordonii can be transformed with plasmid DNA through natural transformation, facilitating genetic manipulation .

  • Established expression systems: Shuttle vectors and promoter systems compatible with S. gordonii have been developed, enabling controlled expression of recombinant proteins .

These characteristics have led researchers to explore S. gordonii as a potential live oral vaccine vehicle and expression system for therapeutic proteins .

What are the most effective expression vectors for recombinant MiaA in S. gordonii?

For expressing recombinant proteins in S. gordonii, including MiaA, several expression systems have proven effective:

  • pDL276-based vectors: The E. coli-Streptococcus shuttle vector pDL276 containing a kanamycin resistance marker has been successfully used for heterologous protein expression in S. gordonii . This vector allows for selection of transformants on media containing kanamycin (typically at 250 μg/ml).

  • Fusion protein approaches: For surface expression, fusion to S. gordonii cell wall proteins has been effective. In particular, the SpaP (surface protein antigen P1) from S. mutans has been used as a fusion partner to direct heterologous proteins to the cell surface of S. gordonii . This approach involves creating an in-frame fusion between the protein of interest and regions of SpaP required for secretion and cell wall anchoring.

  • Promoter selection: For constitutive expression, the native promoters of highly expressed S. gordonii genes can be used. For inducible expression, sugar-regulated promoters might be considered, as S. gordonii exhibits carbon catabolite repression (CCR) mechanisms similar to other streptococci .

When designing an expression system for recombinant MiaA, researchers should consider including epitope tags for detection and purification, and signal sequences if secretion or surface display is desired.

What methodologies are recommended for confirming the expression and localization of recombinant MiaA in S. gordonii?

To confirm the expression and localization of recombinant MiaA in S. gordonii, a multi-faceted approach is recommended:

  • Western blot analysis:

    • Prepare whole cell lysates by treating S. gordonii cells with mutanolysin followed by boiling in SDS-PAGE sample buffer

    • Separate proteins by SDS-PAGE and transfer to membranes

    • Probe with anti-MiaA antibodies or antibodies against fusion tags

    • Expected outcome: Detection of a band at the predicted molecular weight of the MiaA fusion protein

  • Cellular fractionation:

    • Separate cells into wall, membrane, and cytoplasmic fractions

    • Analyze each fraction by Western blotting

    • Expected outcome: Determination of subcellular localization (whether MiaA is cytoplasmic, membrane-associated, or cell wall-anchored)

  • Immunoelectron microscopy:

    • Fix S. gordonii cells and block with BSA and gelatin

    • Incubate with primary antibodies against MiaA or fusion tags

    • Label with gold-conjugated secondary antibodies

    • Visualize by electron microscopy

    • Expected outcome: Gold particles localized to specific cellular compartments indicating MiaA location

  • Functional assays:

    • Develop assays to measure tRNA modification activity

    • Compare the tRNA modification profile between wild-type and recombinant strains

    • Expected outcome: Detection of increased i6A-37 or ms2i6A-37 tRNA modifications in strains expressing recombinant MiaA

This comprehensive approach provides both structural and functional confirmation of recombinant MiaA expression.

How can researchers optimize the transformation efficiency of S. gordonii for recombinant MiaA expression?

Optimizing transformation efficiency for S. gordonii is crucial for successful recombinant MiaA expression. The following methodological approaches are recommended:

  • Natural transformation protocol:

    • Grow S. gordonii to early-mid log phase (OD600 ~0.2-0.3) in Todd-Hewitt broth supplemented with 5% horse serum

    • Add competence-stimulating peptide (CSP, 100 ng/ml final concentration)

    • Incubate for 15 minutes at 37°C

    • Add 0.5-1 μg of plasmid DNA

    • Continue incubation for 2 hours

    • Plate on selective media (e.g., containing kanamycin at 250 μg/ml)

  • Key optimization parameters:

    • Growth phase: Competence in S. gordonii is growth-phase dependent

    • DNA concentration: Too little DNA reduces transformation frequency, while too much can be inhibitory

    • DNA purity: Use high-quality plasmid preparations free from inhibitory contaminants

    • Media composition: Specific nutrients can affect competence development

    • Incubation time: Allow sufficient time for DNA uptake and expression of resistance markers

  • Screening approach:

    • Screen multiple transformants as expression levels can vary

    • Use both molecular (PCR) and protein-based (Western blot) screening methods

    • Evaluate stability of the recombinant constructs over multiple generations

By carefully optimizing these parameters, transformation efficiencies of 103-105 transformants per μg DNA can typically be achieved with S. gordonii.

What methods can be used to assess the enzymatic activity of recombinant MiaA in S. gordonii?

Assessing the enzymatic activity of recombinant MiaA in S. gordonii requires specialized techniques to measure tRNA modification:

  • High-Performance Liquid Chromatography (HPLC) analysis:

    • Extract total tRNA from recombinant S. gordonii strains

    • Enzymatically digest tRNA to nucleosides

    • Analyze by reversed-phase HPLC with UV detection

    • Compare the abundance of i6A-37 or ms2i6A-37 modified nucleosides between recombinant and control strains

    • Expected outcome: Increased peaks corresponding to i6A-37 in MiaA-expressing strains

  • Liquid Chromatography-Mass Spectrometry (LC-MS):

    • More sensitive method for detecting and quantifying modified nucleosides

    • Can distinguish between different modification states

    • Allows absolute quantification of modification levels

    • Expected outcome: Precise quantification of i6A-37 and ms2i6A-37 modifications

  • In vitro enzymatic assays:

    • Prepare cell-free extracts from recombinant S. gordonii

    • Incubate with unmodified tRNA substrates and dimethylallyl pyrophosphate (DMAPP, the prenyl donor)

    • Measure incorporation of the prenyl group using radiolabeled substrates or by HPLC analysis

    • Expected outcome: Extracts from MiaA-expressing strains should show higher prenylation activity

  • Translational fidelity reporters:

    • Introduce reporter constructs containing UNN codons or frameshift-prone sequences

    • Compare expression levels between wild-type and recombinant strains

    • Expected outcome: MiaA expression should enhance translation of UNN-rich sequences and reduce frameshifting

These methodologies allow for both direct measurement of tRNA modification and assessment of the functional consequences of MiaA activity.

How does recombinant MiaA expression affect the proteome profile of S. gordonii?

The expression of recombinant MiaA in S. gordonii would be expected to alter the proteome profile in several ways, based on studies of MiaA in other bacterial species:

  • Impact on UNN codon-enriched proteins:

    • Proteins with high UNN codon content would likely show increased expression levels due to enhanced translational efficiency

    • This effect would be most pronounced for genes with clusters of UNN codons or where UNN codons are located at critical positions

  • Effects on translational fidelity:

    • Reduced frameshifting errors would lead to increased production of full-length proteins

    • This effect would be most noticeable for proteins encoded by genes containing frameshift-prone sequences

  • Stress response modulation:

    • Expression of stress response proteins may be altered due to MiaA's role in post-transcriptional regulation

    • Both direct effects (translation of stress genes) and indirect effects (altered cellular physiology) are possible

  • Potential proteome-wide effects:

    • Changes in MiaA levels have been shown to profoundly alter the bacterial proteome through multiple processes in E. coli

    • Similar effects might occur in S. gordonii, potentially affecting virulence factors, adhesins, and metabolic enzymes

To experimentally characterize these effects, comparative proteomics approaches are recommended:

  • 2D gel electrophoresis followed by mass spectrometry

  • Liquid chromatography-tandem mass spectrometry (LC-MS/MS)

  • Ribosome profiling to assess translational efficiency of different mRNAs

  • RNA-seq in parallel to distinguish translational from transcriptional effects

What are the comparative differences in tRNA modification patterns between native and recombinant MiaA in S. gordonii?

Comparing tRNA modification patterns between native and recombinant MiaA in S. gordonii would reveal important insights into the enzyme's function and regulation. Although specific data for S. gordonii MiaA is not directly available in the search results, we can outline the methodological approach and expected findings based on knowledge of MiaA in other bacterial species:

Methodological approach:

  • tRNA isolation and analysis:

    • Extract total tRNA from wild-type S. gordonii and strains expressing recombinant MiaA

    • Fractionate tRNAs by 2D gel electrophoresis or affinity purification methods

    • Analyze modification status using LC-MS/MS techniques

  • Modification site mapping:

    • Use reverse transcription stops or mass spectrometry to identify and quantify specific modifications

    • Focus on tRNAs that recognize UNN codons, which are the primary targets of MiaA

Expected comparative differences:

ParameterWild-type S. gordoniiRecombinant MiaA Overexpression
i6A-37 modification frequencyBaseline levelsIncreased levels in UNN-decoding tRNAs
ms2i6A-37 modificationDependent on native MiaB activityPotentially increased if MiaB is not limiting
Modification under stressRegulated by native mechanismsPotentially constitutive if under non-native promoter
tRNA species modifiedNative subset of tRNAsPossibly broader range of tRNA substrates
Impact on other modificationsBaseline interactionsPotential competition with other modification pathways

These differences would reflect not only the direct enzymatic activity of recombinant MiaA but also its integration into the existing tRNA modification network of S. gordonii. Understanding these differences is crucial for interpreting any phenotypic effects observed in recombinant strains.

How can recombinant MiaA expression in S. gordonii be used to study the role of tRNA modifications in biofilm formation?

Recombinant MiaA expression provides a powerful tool to investigate the connection between tRNA modifications and biofilm formation in S. gordonii. This research approach leverages S. gordonii's natural biofilm-forming capabilities and the regulatory role of MiaA in tRNA modification:

Experimental approach:

  • Construct expression system:

    • Create S. gordonii strains with controlled expression of MiaA (constitutive, inducible, or varying expression levels)

    • Include appropriate controls (wild-type, vector-only, catalytically inactive MiaA mutants)

  • Biofilm analysis methods:

    • Static biofilm assays in microtiter plates with crystal violet staining

    • Flow cell biofilm models for dynamic formation assessment

    • Confocal laser scanning microscopy for structural analysis

    • Live/dead staining to assess viability within biofilms

  • Comparative analyses:

    • Measure biofilm formation efficiency under different conditions (nutrient availability, pH, presence of saliva)

    • Assess biofilm architecture, extracellular matrix composition, and cell-cell interactions

    • Evaluate the impact of MiaA expression on interspecies competition within mixed biofilms

Previous research has shown that S. gordonii is a pioneer colonizer of dental plaque and plays key roles in interspecies competition within oral biofilms . The SsnA nuclease of S. gordonii, for example, influences biofilm formation in a pH-dependent manner and regulates competition with cariogenic species like S. mutans . Similarly, MiaA-mediated tRNA modifications might influence:

  • Expression of adhesins and surface proteins critical for initial attachment

  • Production of extracellular matrix components

  • Stress response mechanisms that enable persistence under adverse conditions

  • Communication systems that coordinate biofilm development

This research could reveal previously unrecognized connections between translational fidelity, stress response, and biofilm development in oral streptococci.

What insights into translational regulation can be gained from studying recombinant MiaA in S. gordonii?

Studying recombinant MiaA in S. gordonii can provide valuable insights into translational regulation mechanisms in streptococci and other gram-positive bacteria:

  • Codon usage optimization:

    • By manipulating MiaA levels, researchers can assess how tRNA modifications influence the translation of genes with different codon biases

    • This can reveal whether S. gordonii optimizes gene expression through coordinated tRNA modification and codon usage patterns

  • Stress response mechanisms:

    • MiaA has been shown to function as a tunable regulatory nexus in E. coli, with levels shifting in response to stress

    • Investigating whether similar mechanisms exist in S. gordonii would reveal conserved or divergent stress-response strategies

  • Translational recoding:

    • MiaA modifications influence translational frameshifting and recoding events

    • Identifying S. gordonii genes whose expression depends on such mechanisms would reveal new regulatory paradigms

  • Integration with other regulatory networks:

    • Studies in E. coli have shown that MiaA interacts with other RNA and translational modifiers

    • Mapping similar interactions in S. gordonii would provide insights into the architecture of post-transcriptional regulatory networks

Experimental approaches should include:

  • Ribosome profiling to identify translation efficiency changes across the transcriptome

  • RNA-seq in parallel to distinguish translational from transcriptional effects

  • Targeted reporter assays for genes with interesting codon usage patterns

  • Stress response studies comparing wild-type and MiaA-modified strains

These studies could reveal previously uncharacterized mechanisms by which S. gordonii adapts to changing environments, particularly within the complex ecological setting of the oral cavity.

How does recombinant MiaA expression affect interspecies interactions in oral biofilms?

Recombinant MiaA expression in S. gordonii could significantly impact interspecies interactions in oral biofilms through multiple mechanisms. This question addresses an advanced research area that connects molecular modifications with ecological relationships.

Experimental approaches:

  • Mixed-species biofilm models:

    • Co-culture S. gordonii (wild-type and MiaA-expressing strains) with other oral bacteria (e.g., S. mutans, P. gingivalis)

    • Use species-specific fluorescent labels or qPCR for quantitative analysis

    • Assess spatial organization and succession patterns

  • Competition assays:

    • Measure growth inhibition zones in antagonism plate assays

    • Quantify relative fitness in liquid co-cultures

    • Monitor population dynamics in continuous culture systems

  • Molecular interaction studies:

    • Analyze expression of known interspecies communication signals

    • Study the impact on quorum sensing systems

    • Examine adhesin-receptor interactions with partner species

Expected effects on interspecies interactions:

S. gordonii is known to engage in complex relationships with other oral microbes. For example, S. gordonii produces hydrogen peroxide that can inhibit S. mutans, and its arginine deaminase system can counteract acidification of the biofilm . MiaA expression might affect these interactions by:

  • Altering production of antagonistic molecules:

    • Changes in translational efficiency could affect synthesis of antimicrobial compounds

    • Expression of stress response factors that mediate competitive fitness might be modified

  • Influencing environmental modification capabilities:

    • S. gordonii's ability to modify local pH or oxygen levels might be enhanced or diminished

    • This could create more or less favorable conditions for acid-sensitive or acid-tolerant partner species

  • Affecting adhesin expression and biofilm structure:

    • S. gordonii expresses multiple adhesins important for interspecies binding

    • Changes in translational regulation might alter the abundance or presentation of these factors

Based on studies of the SsnA nuclease in S. gordonii, which inhibits biofilm formation by S. mutans in a pH-dependent manner , it's likely that MiaA-mediated translational regulation could similarly affect competitive dynamics in the oral microbiome.

What are the challenges and solutions for using S. gordonii expressing recombinant MiaA as a mucosal delivery vehicle?

Using S. gordonii expressing recombinant MiaA as a mucosal delivery vehicle presents several challenges but also opportunities for innovative solutions:

Challenges:

  • Stability of genetic constructs:

    • Long-term stability of recombinant constructs in the absence of selective pressure

    • Potential for horizontal gene transfer to other oral microbes

  • Controlled expression issues:

    • Ensuring appropriate expression levels of MiaA

    • Avoiding metabolic burden that could reduce fitness in vivo

  • Immune response considerations:

    • Potential host immune responses against both the bacterial vector and MiaA

    • Need to avoid unwanted inflammatory responses in mucosal tissues

  • Delivery and colonization:

    • Ensuring efficient colonization of target mucosal sites

    • Competition with existing microbiota

Solutions and approaches:

  • Genetic stabilization strategies:

    • Chromosomal integration rather than plasmid-based expression

    • Use of balanced-lethal systems for maintenance without antibiotics

    • Conditional expression systems linked to environmental signals

  • Expression optimization:

    • Development of inducible promoter systems responsive to specific signals

    • Fusion to secretion or surface display signals from S. gordonii proteins

    • Creation of attenuated strains with reduced metabolic burden

  • Immunomodulation approaches:

    • Co-expression of immunomodulatory molecules

    • Selection of minimally immunogenic strain backgrounds

    • Development of transient colonization strategies

Previous research has successfully used S. gordonii to express and deliver therapeutic molecules. For example, S. gordonii was engineered to express the microbicidal molecule H6 (an antiidiotypic single chain antibody) both as a secreted protein and as a surface-displayed molecule . This recombinant strain showed promising therapeutic activity in a rat model of vaginal candidiasis, demonstrating the potential of S. gordonii as a mucosal delivery vehicle .

Similarly, S. gordonii has been used to surface-express the S1 subunit of Bordetella pertussis toxin, creating a potential oral vaccine candidate . These precedents suggest that with appropriate optimization, S. gordonii could be developed as a vehicle for delivering MiaA or MiaA-regulated products to mucosal surfaces.

How can researchers design experiments to distinguish between direct and indirect effects of recombinant MiaA expression in S. gordonii?

Distinguishing between direct and indirect effects of recombinant MiaA expression requires careful experimental design. This advanced research question addresses the complexity of tRNA modification networks and their downstream consequences:

Experimental design strategies:

  • Catalytic mutant controls:

    • Create catalytically inactive MiaA mutants (point mutations in active site)

    • Compare effects of wild-type MiaA vs. inactive MiaA expression

    • This distinguishes between effects requiring enzymatic activity and those due to protein presence alone

  • Temporal analysis approaches:

    • Use inducible expression systems to track the time course of changes

    • Immediate changes (minutes to hours) likely represent direct effects

    • Delayed responses (hours to days) typically indicate indirect effects

    • Time-series proteomics and transcriptomics can map response cascades

  • Target specificity assessment:

    • Identify and quantify specific tRNA modifications using LC-MS/MS

    • Correlate modification patterns with observed phenotypes

    • Use tRNA overexpression to test whether effects can be rescued

  • Metabolic precursor manipulation:

    • Vary availability of dimethylallyl pyrophosphate (DMAPP, the prenyl donor)

    • Test whether phenotypes correlate with modification levels

    • This can distinguish effects due to substrate competition from direct enzymatic consequences

  • Comprehensive data integration:

    • Combine transcriptomics, proteomics, and tRNA modification profiling

    • Use computational modeling to infer causal relationships

    • Identify feedback loops and regulatory networks

This approach recognizes that MiaA can influence cellular physiology through multiple mechanisms. In E. coli, for example, both ablation and forced overproduction of MiaA profoundly altered the proteome through variable effects attributable to UNN content, changes in the catalytic activity of MiaA, or availability of metabolic precursors . Similar complexity is likely in S. gordonii, requiring sophisticated experimental designs to disentangle primary from secondary effects.

What are the most promising applications of recombinant MiaA expression for studying bacterial adaptation to environmental stresses?

Recombinant MiaA expression offers powerful applications for studying bacterial adaptation to environmental stresses, particularly in the context of S. gordonii's natural habitat in the oral cavity:

Key research applications:

  • Acid stress adaptation studies:

    • S. gordonii experiences significant pH fluctuations in the oral environment

    • MiaA activity in S. gordonii may be pH-sensitive, similar to other enzymes like SsnA that show pH-dependent regulation

    • Recombinant MiaA expression could be used to investigate how tRNA modification contributes to acid adaptation

  • Oxidative stress response mechanisms:

    • The oral cavity exposes bacteria to oxygen and reactive oxygen species

    • MiaA-mediated translational control might regulate oxidative stress response proteins

    • Controlled expression systems could reveal how tRNA modification networks respond to oxidative challenges

  • Nutrient limitation response:

    • S. gordonii must adapt to varying nutrient availability

    • MiaA-dependent translation could prioritize specific proteins during starvation

    • Sugar-dependent regulation (as seen with other S. gordonii proteins ) might link MiaA activity to nutritional status

  • Biofilm-specific adaptation:

    • Biofilm growth represents a distinct physiological state with unique stresses

    • MiaA might regulate the transition between planktonic and biofilm lifestyles

    • Recombinant expression could help map the regulatory networks involved in this transition

Experimental approaches:

Stress ConditionExperimental SetupMeasurementsExpected Insights
Acid stresspH gradients, acid shockSurvival, proteome changes, tRNA modification patternsRole of MiaA in acid adaptation mechanisms
Oxidative stressH₂O₂ exposure, aerobic/anaerobic transitionsROS damage markers, antioxidant enzyme expressionContribution of tRNA modification to oxidative stress tolerance
Nutrient limitationCarbon/nitrogen starvation, amino acid limitationGrowth rates, stringent response markersRegulation of resource allocation via translational control
Polymicrobial interactionsCo-culture with competitors/pathogensCompetitive fitness, antagonistic molecule productionImpact on ecological relationships in the oral microbiome

Studies of MiaA in E. coli have shown that this enzyme can act "much like a rheostat that can be used to realign global protein expression patterns" . Applying this concept to S. gordonii could reveal how this commensal organism fine-tunes its physiology to persist in the challenging and dynamic environment of the oral cavity.

What are the common pitfalls in characterizing the activity of recombinant MiaA in S. gordonii and how can they be addressed?

Characterizing recombinant MiaA activity in S. gordonii presents several technical challenges that researchers should anticipate and address:

Common pitfalls and solutions:

  • Low expression levels:

    • Pitfall: Insufficient MiaA protein for detection or functional analysis

    • Solutions:

      • Optimize codon usage for S. gordonii preference

      • Test multiple promoter and ribosome binding site combinations

      • Include positive controls in Western blots and activity assays

      • Consider fusion tags that enhance stability without affecting function

  • Misfolding or improper localization:

    • Pitfall: Expressed protein may be non-functional due to improper folding

    • Solutions:

      • Verify cellular localization using fractionation studies

      • Include appropriate signal sequences if cytoplasmic localization is desired

      • Test expression at lower temperatures to improve folding

      • Consider fusion partners known to express well in S. gordonii

  • Difficulty distinguishing recombinant from native activity:

    • Pitfall: Background activity from native MiaA obscuring recombinant enzyme effects

    • Solutions:

      • Generate miaA knockout strains as backgrounds for expression

      • Use tagged versions of MiaA for selective analysis

      • Employ heterologous MiaA variants with distinguishable modification signatures

      • Develop highly sensitive assays for specific tRNA modifications

  • Substrate availability limitations:

    • Pitfall: Insufficient prenyl donor (DMAPP) for MiaA activity

    • Solutions:

      • Verify precursor metabolite pools in S. gordonii

      • Consider co-expression of pathway enzymes that generate DMAPP

      • Supplement growth media with precursors where possible

      • Monitor cellular metabolism to identify potential bottlenecks

  • Technical challenges in tRNA modification analysis:

    • Pitfall: Difficulty in accurately measuring low-abundance tRNA modifications

    • Solutions:

      • Enrich for specific tRNA species before analysis

      • Use highly sensitive LC-MS/MS methods for detection

      • Develop reporter systems that amplify signals from modified tRNAs

      • Include appropriate internal standards for quantification

When working with recombinant S. gordonii expressing MiaA, researchers should establish careful controls and validation steps at each stage of characterization to ensure that observed effects are truly attributable to MiaA activity.

How can researchers address conflicting data in studies of recombinant MiaA effects on S. gordonii physiology?

Addressing conflicting data is a critical aspect of scientific research, particularly when studying complex systems like recombinant MiaA effects on bacterial physiology. Here's a methodological framework for resolving contradictory findings:

Systematic approach to resolving conflicts:

  • Experimental design reassessment:

    • Evaluate whether differences in strain backgrounds could explain discrepancies

    • Compare growth conditions, media compositions, and environmental factors

    • Assess expression levels and construct designs between studies

    • Consider whether temporal factors (growth phase, induction timing) differ

  • Methodology validation:

    • Implement multiple complementary techniques to measure the same parameter

    • For example, combine Western blotting, activity assays, and MS-based tRNA analysis

    • Establish dose-response relationships to identify threshold effects

    • Use internal controls that should give consistent results regardless of experimental variables

  • Genetic background considerations:

    • Test effects in multiple strain backgrounds of S. gordonii

    • Create defined genetic knockouts to eliminate confounding factors

    • Consider potential compensatory mutations that might arise

    • Sequence verify strains to ensure genetic integrity

  • Contextual dependence analysis:

    • Systematically vary key environmental parameters (pH, nutrient availability, oxygen)

    • Test for interaction effects between MiaA expression and other variables

    • Consider that contradictory results might reflect real biological complexity rather than error

  • Statistical rigor:

    • Ensure appropriate statistical methods and sufficient replication

    • Calculate effect sizes, not just statistical significance

    • Consider sources of biological and technical variation

    • Implement blinding procedures where appropriate

Example resolution strategy for a specific conflict:

If conflicting data emerge regarding whether MiaA overexpression enhances or reduces biofilm formation in S. gordonii, researchers might:

  • Test biofilm formation under multiple conditions (varying media, surfaces, flow rates)

  • Measure MiaA expression levels in each experimental setting to ensure comparable expression

  • Examine tRNA modification profiles to confirm enzymatic activity

  • Evaluate whether differences in strain backgrounds (laboratory adaptations, genetic drift) explain the discrepancy

  • Consider whether threshold effects exist where moderate expression enhances biofilm while high expression inhibits it

This systematic approach recognizes that conflicting data often reflects unrecognized biological complexity rather than experimental error.

What are the critical controls needed for experiments investigating the impact of recombinant MiaA on S. gordonii translational fidelity?

Investigating the impact of recombinant MiaA on translational fidelity requires carefully designed controls to ensure robust and interpretable results. The following controls are critical for experiments in this area:

Essential experimental controls:

  • Strain-related controls:

    • Wild-type S. gordonii (unmodified parent strain)

    • Vector-only control (containing the same plasmid backbone without miaA)

    • Catalytically inactive MiaA mutant (with point mutations in active site)

    • miaA knockout strain (to establish baseline without native enzyme)

    • Complemented knockout strain (to confirm phenotype restoration)

  • Expression-level controls:

    • Inducible expression system with dose-response analysis

    • Western blot verification of MiaA protein levels

    • qRT-PCR measurement of miaA transcript levels

    • Enzymatic activity assays to confirm functional expression

  • Translational fidelity reporters:

    • Dual-luciferase reporters with programmed frameshifting sequences

    • Control reporters without frameshift sites

    • UNN codon-enriched and UNN-depleted reporter variants

    • Reporters with near-cognate codon substitutions

  • tRNA modification controls:

    • LC-MS/MS verification of modification status of target tRNAs

    • Measurement of modification levels in different growth conditions

    • Spike-in standards for quantification of modified nucleosides

    • Unmodified in vitro transcribed tRNAs as negative controls

  • Physiological state controls:

    • Measurements at multiple growth phases

    • Controlled growth conditions (pH, temperature, media composition)

    • Stress and non-stress conditions to detect condition-dependent effects

    • Metabolic precursor availability assessment

Experimental design table for translational fidelity studies:

Control TypeControl ImplementationPurposeExpected Outcome
Genetic controlsmiaA knockout vs. wild-typeEstablish baseline fidelity effectsIncreased frameshifting in knockout
Expression controlsTitrated inducer concentrationsEstablish dose-dependenceDose-dependent improvement in fidelity
Reporter controlsUNN-rich vs. UNN-poor constructsTest codon-specific effectsGreater impact on UNN-rich sequences
Modification controlsLC-MS of tRNA before/after expressionVerify enzymatic activityIncreased i6A-37 in MiaA-expressing strains
Physiological controlsExponential vs. stationary phaseTest growth-phase dependencePotentially different effects by phase
Stress controlsNormal vs. stress conditionsTest stress-dependent regulationPossible stress-specific responses

By implementing this comprehensive set of controls, researchers can confidently attribute observed translational fidelity effects to MiaA activity while accounting for potential confounding factors.

How might CRISPR-Cas9 technologies enhance research on recombinant MiaA in S. gordonii?

CRISPR-Cas9 technologies offer transformative potential for advancing research on recombinant MiaA in S. gordonii through several innovative applications:

  • Precise genomic integration of MiaA variants:

    • CRISPR-Cas9 enables site-specific integration of recombinant miaA into the S. gordonii chromosome

    • This allows for stable expression without antibiotic selection pressure

    • Multiple variants can be created with precise control over integration site

    • Single-copy integration eliminates plasmid copy number variation issues

  • Endogenous promoter replacement:

    • Native miaA promoters can be swapped with inducible or constitutive alternatives

    • This maintains natural genetic context while enabling controlled expression

    • Allows study of MiaA regulation in its native chromosomal location

    • Can create promoter libraries to fine-tune expression levels

  • Domain-specific protein engineering:

    • CRISPR-based base editing enables precise amino acid substitutions

    • This facilitates structure-function studies without complete gene replacement

    • Allows modification of catalytic, regulatory, or interaction domains

    • Can create allelic series to map functional regions of MiaA

  • Multiplexed genetic manipulation:

    • Simultaneous editing of miaA and related genes (e.g., miaB, tRNA genes)

    • Creation of double/triple mutants to study epistatic interactions

    • Systematic deletion of UNN codon-enriched genes to identify MiaA-dependent genes

    • Engineering of synthetic tRNA modification networks

  • High-throughput screening approaches:

    • CRISPR interference (CRISPRi) libraries targeting genes affected by MiaA

    • CRISPR activation (CRISPRa) to upregulate potential MiaA regulators

    • Pooled screens to identify genetic interactions with MiaA

    • Synthetic genetic array approaches to map genetic networks

These CRISPR-based strategies would significantly enhance our ability to understand MiaA function in S. gordonii by enabling precise genetic manipulation beyond what traditional recombinant DNA approaches allow. They would facilitate a systems-level analysis of tRNA modification networks and their role in bacterial physiology and virulence.

What emerging analytical technologies would advance understanding of MiaA-mediated tRNA modifications in S. gordonii?

Emerging analytical technologies offer exciting opportunities to deepen our understanding of MiaA-mediated tRNA modifications in S. gordonii:

  • Nanopore direct RNA sequencing:

    • Allows detection of modified nucleosides in native tRNA without reverse transcription

    • Can reveal modification patterns across the entire tRNA pool

    • Enables identification of combinatorial modification patterns on individual tRNA molecules

    • Requires minimal sample preparation, potentially allowing in situ analysis

  • NAIL-MS (Nucleic Acid Isotope Labeling coupled with Mass Spectrometry):

    • Uses stable isotope labeling to track newly synthesized vs. existing tRNAs

    • Enables kinetic analysis of tRNA modification dynamics

    • Can determine modification rates under different conditions

    • Allows precise quantification of modification turnover

  • Cryo-EM structural analysis:

    • Determination of high-resolution structures of MiaA in complex with tRNA

    • Visualization of conformational changes during the modification process

    • Identification of species-specific structural features of S. gordonii MiaA

    • Structure-guided design of MiaA variants with altered activity

  • Ribo-seq (ribosome profiling) applications:

    • Genome-wide analysis of translation efficiency in relation to tRNA modifications

    • Identification of ribosome pausing sites affected by MiaA activity

    • Direct measurement of frameshifting and translational fidelity in vivo

    • Integration with proteomics to correlate translational and protein-level changes

  • Single-cell analysis technologies:

    • Examination of cell-to-cell variability in tRNA modification levels

    • Assessment of phenotypic heterogeneity resulting from MiaA expression differences

    • Tracking of modification dynamics during cell division and growth

    • Correlation of single-cell modification patterns with physiological states

  • Spatial transcriptomics approaches:

    • Mapping tRNA modification patterns within biofilm structures

    • Analysis of modification gradients in response to environmental cues

    • Correlation of spatial distribution of modified tRNAs with protein expression patterns

    • Understanding the role of tRNA modifications in biofilm development

These emerging technologies would provide unprecedented insights into the dynamics, regulation, and functional consequences of MiaA-mediated tRNA modifications in S. gordonii, potentially revealing new principles of bacterial translational control and stress adaptation.

How might systems biology approaches integrate tRNA modification data with other -omics datasets to reveal global regulatory networks in S. gordonii?

Systems biology approaches offer powerful frameworks for integrating tRNA modification data with other -omics datasets to uncover the global regulatory networks influenced by MiaA in S. gordonii:

Integrative systems biology strategies:

  • Multi-omics data integration pipeline:

    • Generate coordinated datasets spanning multiple levels of biological organization:

      • Genomics: Sequence variation in tRNA genes and MiaA regulators

      • Transcriptomics: mRNA expression patterns under various conditions

      • Epitranscriptomics: tRNA modification profiles and dynamics

      • Proteomics: Global protein abundance and modifications

      • Metabolomics: Metabolic precursors and products related to tRNA modification

    • Develop computational pipelines for integrated analysis across these datasets

    • Implement machine learning approaches to identify patterns and relationships

  • Network modeling approaches:

    • Construct gene regulatory networks incorporating:

      • Transcription factors affecting miaA expression

      • RNA-binding proteins influencing tRNA stability

      • Metabolic enzymes affecting precursor availability

    • Build protein-protein interaction networks to identify MiaA partners

    • Develop metabolic models incorporating tRNA modification reactions

  • Perturbation analysis framework:

    • Systematic genetic perturbations (deletion, overexpression) of network components

    • Environmental perturbations (stress conditions, nutrient limitation)

    • Temporal analysis of system responses to perturbations

    • Identification of network motifs and feedback loops

  • Comparative systems analysis:

    • Compare tRNA modification networks across multiple streptococcal species

    • Identify conserved and species-specific regulatory mechanisms

    • Correlate network architecture with ecological niches and pathogenic potential

    • Elucidate evolutionary constraints on tRNA modification systems

Expected insights and outcomes:

A systems biology approach would likely reveal that MiaA functions as a regulatory hub connecting multiple cellular processes in S. gordonii, similar to its role in E. coli where it acts as a "tunable regulatory nexus" . Specific insights might include:

  • Identification of condition-specific tRNA modification patterns that correlate with specific proteome profiles

  • Discovery of regulatory factors that control MiaA activity in response to environmental signals

  • Mapping of feedback loops connecting translation efficiency, metabolic state, and tRNA modification

  • Understanding how S. gordonii integrates tRNA modification into broader stress response networks

  • Elucidation of how MiaA-mediated translational control influences interspecies interactions in the oral microbiome

This integrative approach would transform our understanding of tRNA modifications from isolated biochemical events to key components of a dynamic regulatory network that enables S. gordonii to thrive in the complex and changing environment of the human oral cavity.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.